RSS   Newsletter   Contact   Advertise with us
Post Online Media

Recro Pharma appoints Bryan Reasons to board

Bryan ReasonsRecro Pharma, a specialty pharmaceutical company, announced the appointment of Bryan Reasons to the company’s board of directors.
Article continues below

READ MORE Recro Pharma appoints Michael Celano as CFO

Mr. Reasons, Senior Vice President and Chief Financial Officer of Impax Laboratories, brings over 20 years of financial leadership experience to Recro’s Board.

Prior to joining Impax in 2012, Mr. Reasons held positions of increasing responsibility at Cephalon, Inc., where he successfully navigated acquisition by Teva Pharmaceutical Industries Ltd..

Mr. Reasons previously served in a number of financial leadership roles at E.I. Du Pont De Nemours and Company and PricewaterhouseCoopers LLP, ranging from corporate accounting, external reporting and audit and business advisory services.

Mr. Reasons earned a bachelor’s degree in accounting from Pennsylvania State University and an M.B.A. from Widener University and is a certified public accountant.

 LATEST MOVES FROM Pennsylvania 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy